Hasil Pencarian - Timothy P. DiPeri

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma

    Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma oleh Timothy P. DiPeri, Mehmet Demirhan, Daniel D. Karp, Siqing Fu, David S. Hong, Vivek Subbiah, Joann Lim, Leomar Y. Ballester, Jean H. Tayar, Maria E. Suarez-Almazor, Milind Javle, Funda Meric-Bernstam

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

    Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan oleh Ming Zhao, Timothy P. DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W. Evans, Fei Yang, Argun Akcakanat, Marco Roberto Estecio, Debu Tripathy, Ecaterina E. Dumbrava, Senthil Damodaran, Funda Meric-Bernstam

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

    Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer oleh Turcin Saridogan, Argun Akcakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott, Bryce P. Kirby, Xiaofeng Zheng, Min Jin Ha, Huiqin Chen, Patrick K. S. Ng, Timothy P. DiPeri, Gordon B. Mills, Jordi Rodon Ahnert, Senthil Damodaran, Funda Meric-Bernstam

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

    A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients oleh Timothy P. DiPeri, MD, Timothy E. Newhook, MD, Ryan W. Day, MD, Yi-Ju Chiang, MSPH, Whitney L. Dewhurst, MS, AGNP-C, Elsa M. Arvide, MS, PA-C, Morgan L. Bruno, MS, ACNP-BC, Christopher P. Scally, MD, MS, Christina L. Roland, MD, MS, Matthew H.G. Katz, MD, Jean-Nicolas Vauthey, MD, George J. Chang, MD, MS, Brian D. Badgwell, MD, MS, Nancy D. Perrier, MD, Elizabeth G. Grubbs, MD, Jeffrey E. Lee, MD, Ching-Wei D. Tzeng, MD, Brian K. Bednarski, MD, Iris B. Chen, MS, APRN, Ryan J. Comeaux, MS, PA-C, Dana M. Cox, MPAS, PA-C, Barry W. Feig, MD, Sarah B. Fisher, MD, Keith F. Fournier, MD, Semhar J. Ghebremichael, MD, Heather M. Gibson, MS, PA-C, Nicole C. Gourmelon, MS, PA-C, Paul H. Graham, MD, Shannon Hancher, MD, Kelly K. Hunt, MD, Naruhiko Ikoma, MD, MPH, Shanae L. Ivey MPAS, PA-C, Emily Z. Keung, MD, Celia R. Ledet, MD, Angela R. Limmer, MS, PA-C, Paul F. Mansfield, MD, Lauren K. Mayon, MS, PA-C, Craig A. Messick, MD, Keyuri U. Popat, MD, Nikita F. Rajkot MPAS, PA-C, Justine L. Robinson MPAS, PA-C, Kristen A. Robinson MPAS, PA-C, Miguel A. Rodriguez-Bigas, MD, David A. Santos, MD, MS, John M. Skibber, MD, B. Bryce Speer, DO, Jose Soliz, MD, Matthew M. Tillman, MD, Keila E. Torres, MD, Antoinette van Meter, MD, Marla E. Weldon, MS, PA-C, Uduak Ursula Williams, MD, Y. Nancy You, MD, MHSc

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: